Maksim Royzen

Tambo, Inc.

NIH Rank #13137
  • Early Career

NIH Funding · FY2024

Total Funding
$1.1M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#13,137
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.1M across 2 grants · National rank #13137.

Top grants by award amount

Maksim Royzen's NIH grant portfolio, ranked by award amount.

  • 2R44TR004026-02R44
    Discovery of solubilizing side chains for in vivo release of diverse drug classes using the Click Activated Protodrugs (CAP) platform
    $929.7K
    award amount
  • 5R21HG012257-03R21
    Synthesis and non-chromatographic purification of long RNA oligonucleotides containing naturally occurring modification
    $193.9K
    award amount

Affiliations

Institutions that have administered grants for Maksim Royzen.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Tambo, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Maksim Royzen.